BNET Industries
Last Fiscal Year Sales:$293.7M
- Private
- US
Dow Jones Description
We are a leading global provider of high-quality, orthopedic devices, with a broad range of products used for rehabilitation, pain management and physical therapy. We also develop, manufacture and distribute a broad range of surgical reconstructive implant products. We are the largest non-surgical orthopedic rehabilitation device company in the United States and among the largest globally, as measured by revenues. Many of our products have leading market positions. We believe that our strong brand names, comprehensive range of products, focus on quality, innovation and customer service, extensive distribution network, and our strong relationships with orthopedic and physical therapy professionals have contributed to our leading market positions. We believe that we are one of only a few orthopedic device companies that offer healthcare professionals and patients a diverse range of orthopedic rehabilitation products addressing the complete spectrum of preventative, pre-operative, post-operative, clinical and home rehabilitation care. Our products are used by orthopedic specialists, spine surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events and sports-related injuries. ...
Number of Employees 1,300
Peer Companies
NAICS Code Sanitary Paper Product Manufacturing: 322291
Recent Events
-
DJO Incorporated Announces Financial Results for Third Quarter 2009
News & Analysis
Filter by
reable therapeutics inc. - All News and Analysis
Top companies report: a comprehensive look at the biggest worldwide orthopedic manufacturers
- 2008-07-01
Top of Their Game Every year, Orthopedic Design & Technology examines the top 10 performing orthopedic firms. As with issues past, companies are ranked by revenue for the last full fiscal year--in this case, 2007. To provide insight into a company's performance, we looked at new product launches, research...
Research and Markets: New Publication Assesses Strengths, Weaknesses, Opportunities and Threats to ReAble Therapeutics Finance LLC
- 2008-03-04
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c84602) has announced the addition of ReAble Therapeutics Finance LLC Strategic Analysis Profile to their offering. * The ReAble Therapeutics Finance LLC Strategic Analysis Profile is a comprehensive profile of the company including both quantitative and qualitative research. The report examines the company's...
New Publication Assesses Strengths, Weaknesses, Opportunities and Threats to ReAble Therapeutics Finance LLC.
- 2008-03-03
M2 PRESSWIRE-3 March 2008-Research and Markets: New Publication Assesses Strengths, Weaknesses, Opportunities and Threats to ReAble Therapeutics Finance LLCC1994-2008 M2 COMMUNICATIONS LTD RDATE:04032008 Dublin - Research and Markets (http://www.researchandmarkets.com/reports/c84605) has announced the addition of ReAble Therapeutics Finance LLC...
Research and Markets: Examine ReAble Therapeutics Finance LLC's Major Financial Deals Whilst Learning Their Key Business Structure and Operations
- 2007-12-03
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c76047) has announced the addition of "ReAble Therapeutics Finance LLC's Major Financial Deals and Alliances Profile" to their offering. This profile is an essential source for company data and information. The profile examines ReAble Therapeutics Finance LLC's key business structure and operations, history...
DJO Incorporated Closes Merger Transaction with ReAble Therapeutics
- 2007-11-20
SAN DIEGO -- DJO Incorporated, (NYSE:DJO), a global provider of products and services that promote musculoskeletal and vascular health, announced the completion of its Agreement and Plan of Merger, dated as of July 15, 2007, with ReAble Therapeutics, Inc., effective today, November 20, 2007. Pursuant to the terms of the...
Iomed says merger amount for ReAble has been set
- 2007-08-02
Salt Lake-based Iomed Inc. said that the per-share amount for its merger with ReAble Therapeutics has been set. Iomed shareholders will receive cash equal to $2.75 per share in exchange for their Iomed common stock if the merger agreement is approved by Iomed shareholders. Iomed's board...
DJO Enters into Merger Agreement with ReAble Therapeutics, Inc.
- 2007-07-16
M2 PRESSWIRE-16 July 2007-ExplorationInvestor: DJO Enters into Merger Agreement with ReAble Therapeutics, Inc.C1994-2007 M2 COMMUNICATIONS LTD RDATE:16072007 Exploration Investor strives to provide you with outstanding market results. We will be your number one resource for all your small and large...
Iomed is merging with Texas' ReAble
- 2007-05-19
Salt Lake-based Iomed Inc. announced plans Friday to merge with ReAble Therapeutics Inc., a Texas-based medical device company, in a deal valued at about $22 million. As part of the transaction, ReAble will buy all of Iomed's outstanding shares (about 7.68 million) for $2.75 per share, a price...
- 1
Industry Transcripts by Seeking Alpha
-
Brown Shoe Co. Inc. Q3 2009 Earnings Call Transcript
on Nov 24, 2009about BWS
-
Daktronics Inc. F2Q10 (Qtr End 31/10/09) Earnings Call Transcript
on Nov 24, 2009about DAKT
-
Haynes International Inc. F4Q09 (Qtr End 09/30/09) Earnings Call Transcript
on Nov 24, 2009about HAYN
-
Valspar Corp. F4Q09 (Qtr End 30/10/09) Earnings Call Transcript
on Nov 23, 2009about VAL
-
Donaldson Company Inc. F1Q10 (Qtr End 31/10/09) Earnings Call Transcript
on Nov 19, 2009about DCI
Glass Door
Manufacturing Industry Companies
| Company | Employer Rating |
| Alcoa |  |
| United Technologies | |
| BAE SYSTEMS (United Kingdom) | |
| Textron |  |
| Boeing | |
IndustryTop Rated
